International Biotechnology Trust plc (IBT) — Cash Flow Quality Index
International Biotechnology Trust plc (IBT) has a Cash Flow Quality Index of -0.38x as of February 2025. Operating cash flow of GBX-2.67 Million is below net income of GBX7.03 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore International Biotechnology Trust plc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
International Biotechnology Trust plc Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for International Biotechnology Trust plc across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check International Biotechnology Trust plc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for International Biotechnology Trust plc (2011–2024)
Year-by-year earnings quality comparison for International Biotechnology Trust plc. For live market cap and the full company financial profile, see International Biotechnology Trust plc (IBT) market capitalisation.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | GBX45.35 Million | GBX38.88 Million | ▼ -70.4% |
| 2023 | 3.94x | GBX27.30 Million | GBX6.93 Million | ▲ +859.7% |
| 2021 | -0.52x | GBX-14.53 Million | GBX28.05 Million | ▼ -190.7% |
| 2020 | -0.18x | GBX-9.55 Million | GBX53.59 Million | ▼ -122.1% |
| 2018 | 0.81x | GBX16.17 Million | GBX20.01 Million | ▲ +149.0% |
| 2017 | 0.32x | GBX14.71 Million | GBX45.32 Million | ▼ -34.5% |
| 2015 | 0.50x | GBX38.90 Million | GBX78.53 Million | ▲ +1093.6% |
| 2014 | -0.05x | GBX-2.23 Million | GBX44.75 Million | ▼ -27616.1% |
| 2013 | 0.00x | GBX-8.00K | GBX44.48 Million | ▼ -100.1% |
| 2012 | 0.30x | GBX11.37 Million | GBX38.07 Million | ▲ +152.1% |
| 2011 | -0.57x | GBX-2.64 Million | GBX4.61 Million | — |